Intrust Bank NA Sells 44 Shares of Mettler-Toledo International, Inc. $MTD

Intrust Bank NA reduced its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 9.5% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 420 shares of the medical instruments supplier’s stock after selling 44 shares during the period. Intrust Bank NA’s holdings in Mettler-Toledo International were worth $493,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. WPG Advisers LLC bought a new stake in Mettler-Toledo International in the first quarter valued at approximately $41,000. NewSquare Capital LLC boosted its stake in shares of Mettler-Toledo International by 94.4% during the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 17 shares during the period. MV Capital Management Inc. increased its holdings in shares of Mettler-Toledo International by 50.0% during the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 12 shares during the last quarter. Zions Bancorporation National Association UT bought a new stake in Mettler-Toledo International in the 1st quarter valued at $43,000. Finally, Sound Income Strategies LLC raised its stake in Mettler-Toledo International by 477.8% in the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock valued at $61,000 after acquiring an additional 43 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Buying and Selling

In related news, CEO Patrick Kaltenbach sold 2,000 shares of the stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total transaction of $2,925,000.00. Following the sale, the chief executive officer owned 3,670 shares of the company’s stock, valued at $5,367,375. This represents a 35.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider La Guerroniere Marc De sold 6,880 shares of Mettler-Toledo International stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the completion of the transaction, the insider directly owned 187 shares of the company’s stock, valued at $271,150. This represents a 97.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 11,249 shares of company stock worth $16,338,723. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Stock Performance

NYSE:MTD opened at $1,398.50 on Wednesday. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,471.06. The firm has a market cap of $28.57 billion, a price-to-earnings ratio of 35.41, a P/E/G ratio of 4.19 and a beta of 1.41. The firm’s 50-day simple moving average is $1,338.33 and its 200 day simple moving average is $1,255.33.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. During the same quarter in the previous year, the firm posted $10.21 EPS. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Wall Street Analyst Weigh In

MTD has been the subject of a number of research analyst reports. Stifel Nicolaus lifted their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Robert W. Baird lifted their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. JPMorgan Chase & Co. upped their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Evercore ISI raised their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Five analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,406.50.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.